Frontiers Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
Por um escritor misterioso
Last updated 22 setembro 2024
Frontiers in Pharmacology Pharmacogenetics and Pharmacogenomics
Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations
Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia
Frontiers Retrospective analysis of outcomes for pediatric acute lymphoblastic leukemia in South American centers
Frontiers Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology
Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response
Frontiers Prophylactic alpha blockers fail to prevent postoperative urinary retention following orthopaedic procedures: evidence from a meta-analysis and trial sequential analysis of comparative studies
Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response
Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients
Frontiers Retrospective analysis of outcomes for pediatric acute lymphoblastic leukemia in South American centers
IJMS, Free Full-Text
Recomendado para você
você pode gostar